Alantra advises Helios Medical Communications agency on investment by NorthEdge
SECTORHealthcare
ServiceM&A
London – Alantra, the independent global mid-market investment banking firm, has advised the shareholders of Helios Medical Communications (Helios), a full-service, independent, global healthcare communications and strategic consultancy, on partnering with mid-market private equity firm NorthEdge to support their next growth phase.
Based in Cheshire, Helios works with global pharmaceutical clients to deliver high-quality, high-impact bespoke solutions across a range of services including medical writing, advisory boards, training and symposia.
Helios, which ranked 17th on the Sunday Times 2020 FastTrack, has achieved growth through a commitment to excellence in delivery, facilitated by investment in people and a focus on team culture.
NorthEdge’s investment will support Helios’ future growth plans. In addition to expanding its existing locations in Cheshire and Oxfordshire, the business is set to launch a new central Manchester office in early 2021, and will also evaluate options for future international expansion.
Alantra’s Healthcare team was appointed due to its significant experience of working with healthcare communications businesses, finding strategic partners and securing investment solutions. Their role encompassed advising the shareholders on the options available to support the next stage of Helios’ growth, designing the deal structure and pricing, identifying potential partners and supporting the team to enable an efficient process through to completion.
Andrew Minnock, Managing Director of Helios, commented: “We were hugely impressed by Alantra’s expertise and experience in the healthcare communications space and it was clear from the outset that they were going to be a strong partner. Anthony, Tom and the team were instrumental in shaping the deal, guiding us through a complicated process and achieving a great result for all parties involved. Helios is a brilliant company and we are very excited to deliver our plan for the business over the next few years.”
Related Transactions
-
Jun 2026
Sell-side advisory
Jun 2026SECTOR Consumer Goods & Retail; HealthcareService M&A -
Jan 2026
Sell-side advisory
Jan 2026SECTOR Consumer Goods & Retail; HealthcareService M&A -
Dec 2025
Buy-side advisory
Dec 2025SECTOR HealthcareService M&A -
Dec 2025
Sell-side advisory
Dec 2025SECTOR HealthcareService M&A